Experience with cardiovascular risk model offers useful lessons
September 19th 2005San Francisco - Many parallels can be drawn between glaucoma and coronary heart disease - both are chronic diseases that can be depicted on a continuum of progression from disease that is first undetectable, then asymptomatic, and ultimately results in functional impairment - and both are associated with a modifiable causal risk factor (IOP and serum cholesterol) that when treated effectively results in a reduction in disease progression risk.
More sensitive tests aim to detect glaucoma-related function and structure changes
September 19th 2005San Francisco - Developers of specialized perimetric tests and quantitative optic nerve and retinal nerve fiber layer (RNFL) analyzers have introduced hardware and software modifications to improve those new tools for assessing function and structure in patients with glaucoma. However, their roles in clinical practice still await definition pending further study, said Christopher A. Girkin, MD, MPH, associate professor of ophthalmology and director, glaucoma service, Callahan Eye Foundation Hospital, University of Alabama at Birmingham.
First glaucoma risk calculator set to debut
September 19th 2005San Francisco - A newly developed risk calculator will make therapeutic decision-making for patients with ocular hypertension a little more straightforward, said Robert N. Weinreb, MD, director, Hamilton Glaucoma Center, and distinguished professor of ophthalmology, University of California, San Diego.
Epidemiology studies highlight glaucoma public health impact
September 19th 2005San Francisco - Statistics released by the World Health Organization (WHO) in 2002 indicate glaucoma has become a more common cause of blindness than it was in the past, said Anne L. Coleman, MD, PhD, the Frances and Ray Stark Professor of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles.
Experts highlight latest advances, care at Glaucoma 2005
September 19th 2005San Francisco - A panel of glaucoma experts from across the United States highlighted the latest advances in understanding glaucoma and caring for these patients at “Glaucoma 2005: Mastering Tools and Techniques for the 21st Century,” on Saturday, Sept. 17, at the Ritz-Carlton San Francisco. Now in its 5th year, the program included lectures, panel discussions, and a mini-symposium covering a variety of glaucoma issues with a distinguished faculty.
Glaucoma treatment costs present economic ramifications
September 15th 2005Fort Lauderdale, FL—The economic ramifications of treating ocular hypertension and glaucoma bring some serious questions into the spotlight, notably the costs of treatment and especially the increased rate of cataract extractions associated with the use of anti-glaucoma eye drops. Harry Quigley, MD, considered these issues at the annual meeting of the Association for Research in Vision and Ophthalmology.
Photoscreening efforts for preschoolers need guidance
September 15th 2005Orlando—A review of 17 volunteer-led preschool photoscreening programs indicates that such programs can be highly successful but that strong, preferably paid, administrative leadership is crucial in ensuring adequate rates of follow-up and referral, according to Sean P. Donahue, MD, PhD, associate professor of ophthalmology and visual sciences, pediatrics, and neurology at Vanderbilt University Medical Center, Nashville, TN, and chief of ophthalmology, Monroe Carell Jr. Children's Hospital at Vanderbilt.
Glaucoma treatment costs present economic ramifications
September 15th 2005Fort Lauderdale, FL—The economic ramifications of treating ocular hypertension and glaucoma bring some serious questions into the spotlight, notably the costs of treatment and especially the increased rate of cataract extractions associated with the use of anti-glaucoma eye drops. Harry Quigley, MD, considered these issues at the annual meeting of the Association for Research in Vision and Ophthalmology.
Varying lens power profiles appear to be visually inconsequential
September 15th 2005Sydney, Australia—Currently available soft contact lenses vary substantially in their optic zone refractive power distribution, and labeled lens power may not correspond exactly to the effective power of the lens on the eye. However, with attention to proper lens fitting, the power profile differences do not appear to result in measurable differences on short-term visual performance, according to the results of a study undertaken by Australian researchers.
Photoscreening efforts for preschoolers need guidance
September 15th 2005Orlando—A review of 17 volunteer-led preschool photoscreening programs indicates that such programs can be highly successful but that strong, preferably paid, administrative leadership is crucial in ensuring adequate rates of follow-up and referral, according to Sean P. Donahue, MD, PhD, associate professor of ophthalmology and visual sciences, pediatrics, and neurology at Vanderbilt University Medical Center, Nashville, TN, and chief of ophthalmology, Monroe Carell Jr. Children's Hospital at Vanderbilt.
Coaxial 2.2-mm microphacoemulsification reduces surgically induced astigmatism
September 13th 2005Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision results in significantly less induced astigmatism than conventional coaxial phacoemulsification through a 3-mm incision, said Samuel Masket, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, University of California-Los Angeles, United States.
Wavefront-guided enhancement of highly aberrated eyes safe, predictable in study
September 13th 2005Lisbon, Portugal - Preliminary data have demonstrated that VISX CustomVue wavefront-guided enhancement of eyes with high aberrations after a previous refractive surgery is safe and effective. Edward Manche, MD, described the retrospective analysis of 120 eyes of 102 patients Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
EpiLASIK efficacious 1 year after treatment with low patient discomfort, study finds
September 13th 2005Lisbon, Portugal - EpiLASIK is a safe and effective alternative refractive procedure to treat patients with myopia. The 1-year data indicate that the patients have good refractive results and stable vision. Vikentia Katsanevaki, MD, PhD, described the study Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Coaxial 2.2-mm microphacoemulsification reduces surgically induced astigmatism
September 13th 2005Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision results in significantly less induced astigmatism than conventional coaxial phacoemulsification through a 3-mm incision, said Samuel Masket, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, University of California-Los Angeles, United States.
Customized LASIK provides measurable clinical and economic benefits
September 13th 2005Lisbon, Portugal - A shift from conventional to wavefront-guided LASIK has resulted in reduced enhancement rates that translate into significant cost savings to the practice, said Richard L. Lindstrom, MD, adjunct professor emeritus, department of ophthalmology, University of Minnesota, and founding partner, Minnesota Eye Consultants, Minneapolis, United States.
Beta-blocker effective to manage regression after refractive surgery
September 13th 2005Lisbon, Portugal - Treatment with a topical beta-blocker is effective for preventing regression after LASIK to treat myopia. However, there is no way to predict which patients will respond to the therapy, according to Takayoshi Suzuki, MD, who reported his findings Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Mitomycin C aids corneal healing after photoablation
September 13th 2005Lisbon, Portugal - Application of mitomycin C after PRK prevents the development of corneal haze and improves visual acuity. Ewa Mrukwa-Kominek, MD, reported these findings Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Goblet cell dysfunction may occur after LASIK
September 13th 2005Lisbon, Portugal - Dry eye syndrome after LASIK may be the result of goblet cell dysfunction. Extended application of artificial tears may be warranted to facilitate the return to normal function, Ahmed Galal, MD, PhD, said Tuesday at the European Society of Cataract and Refractive Surgeons meeting.
Nidek receives CE Mark for excimer laser system
September 12th 2005Lisbon, Portugal - Nidek Co., Gamagori, Japan, has received a CE Mark for its new and advanced refractive surgery laser system, the EC-5000CXIII. This regulatory milestone clears the way for NIDEK to commercialize and market the new laser platform for refractive surgery, throughout the world, especially in Europe and the Middle East, the company said.
Artiflex and I-Care phakic IOLs are accurate; some complications exist with both, study finds
September 12th 2005Lisbon, Portugal - Both the Artiflex (Ophtec) iris-claw IOL and the I-Care (Cornéal) phakic angle-supported IOL are effective and provide good refractive outcomes, Antonio Marinho, MD, reported Monday at the European Society of Cataract and Refractive Surgeons meeting.
Duet-Kelman phakic IOL seems safe and efficacious 1 year after implantation
September 12th 2005Lisbon, Portugal - The Duet-Kelman phakic lens seems to be safe and efficacious to correct moderate and high degrees of myopia, and patients with high degrees of myopia expressed satisfaction with their increased vision, according to Gonzalo Bernabeu, MD. He reported his experience with the IOL Monday at the European Society of Cataract and Refractive Surgeons meeting.
Risk factors associated with endophthalmitis after cataract surgery
September 12th 2005Lisbon, Portugal - Data on the development of endophthalmitis have been reported continuously since 1994 in Sweden, and the rate of endophthalmitis has been decreasing similar to international rates. Per Montan, MD, reported the results of a multicenter study on the risk factors that have been identified for the development of endophthalmitis Monday at the European Society of Cataract and Refractive Surgeons meeting.
ASCRS/ESCRS survey: Dislocation, decentration top reasons for foldable IOL explantation
September 12th 2005Lisbon, Portugal - The results of the 7th annual survey on foldable IOLs indicate that dislocation and decentration are by far the most common reasons for lens explantation, with incorrect lens power the next most important factor. Nick Mamalis, MD, reported the results of the survey - conducted by the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgeons (ESCRS) - Monday morning at ESCRS’ annual meeting.
Coaxial microphaco a major step forward in cataract surgery evolution
September 12th 2005Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision is a new technique that can be readily learned by cataract surgeons skilled in phacoemulsification. The technique affords patients the combined benefits of ultra-small incision surgery and conventional foldable IOLs, Robert H. Osher, MD, said Monday at the European Society of Cataract and Refractive Surgeons meeting.